2960 studies found for:    Open Studies | Studies received in the last 60 days
Show Display Options
Rank Status Study
1 Recruiting Prospective Evaluation of Adjusted Body Weight Dosing of Acyclovir in Obesity
Condition: Obesity
Intervention:
2 Not yet recruiting A Clinical Trial of Durvalumab (MEDI4736) as 1st Line Therapy in Advanced Non-small Cell Lung Cancer Patients With ECOG Performance Status of 2
Condition: Non Small Cell Lung Cancer
Intervention: Drug: durvalumab
3 Not yet recruiting Cost-utility Study of a Group of Compensatory Cognitive Remediation in Schizophrenia
Condition: Schizophrenia
Interventions: Other: Compensatory cognitive training;   Other: Usual
4 Recruiting Enhancing Social Interaction With an AlterEgo Artificial Agent
Condition: Schizophrenia
Intervention: Other: Social Skills training with Avatar therapist
5 Recruiting Cochlear Implant Low Power Strategy
Condition: Hearing Loss
Intervention: Device: MP3000 sound coding strategy or ACE strategy with lower stimulation
6 Recruiting Chidamide Combined With Cyclophosphamide、Prednisone、Thalidomide in Treatment of Fragile Patients With Relapse/Refratory Peripheral T Cell Lymphoma
Condition: Relapse/Refratory Peripheral T Cell Lymphoma
Intervention: Drug: C-CPT
7 Recruiting Trial of Adjuvant Chemotherapy in Breast Cancer Patients With Pathological Partial Response to Neoadjuvant Chemotherapy
Conditions: Invasive Ductal Breast Cancer;   Tubular Breast Cancer;   Mucinous Breast Cancer;   Inflammatory Breast Cancer
Interventions: Drug: Paclitaxel;   Drug: Cisplatin;   Drug: Epirubicin;   Drug: Cyclophosphamide;   Drug: 5-fluoruracil
8 Recruiting Vaginal Cuff Dehiscence at Total Laparoscopic Hysterectomy
Condition: Surgical Wound Dehiscence
Intervention: Device: Monopolar needle electrode
9 Not yet recruiting AMPLATZER™ Amulet™ Left Atrial Appendage Occluder Randomized Controlled Trial
Condition: Stroke
Interventions: Device: Amulet Left Atrial Appendage Occluder;   Device: WATCHMAN Left Atrial Appendage Closure
10 Recruiting Genetic Markers and Proliferative Diabetic Retinopathy
Condition: Proliferative Diabetic Retinopathy
Intervention: Genetic: genetic analysis
11 Not yet recruiting HbA1c Variability in Type II Diabetes
Condition: Diabetes Mellitus Type 2
Interventions: Drug: Metformin;   Drug: Gliclazide;   Drug: Sitagliptin;   Drug: Liraglutide;   Drug: Pioglitazone;   Drug: Dapagliflozin;   Drug: human insulin
12 Not yet recruiting Preventing Avoidable Admissions Among Assisted Living Elders
Conditions: Aging;   Emergencies
Intervention: Behavioral: PA4LE Program
13 Not yet recruiting Effect of DMR Using the Revita System in the Treatment of Type 2 Diabetes (T2D)
Conditions: Diabetes Mellitus, Type 2;   Noninsulin-Dependent Diabetes Mellitus
Interventions: Procedure: DMR Procedure;   Procedure: Sham Procedure
14 Not yet recruiting Clinical Study to Evaluate the Exercise Capacity in Patients With Severe Emphysema Treated With Coils
Condition: Pulmonary Emphysema
Interventions: Procedure: 10 coils in upper lobes;   Procedure: 15 coils in upper and lower lobes;   Procedure: cycloergometry
15 Not yet recruiting Gemcitabine and Nab-Paclitaxel vs Gemcitabine, Nab-Paclitaxel, Durvalumab and Tremelimumab as 1st Line Therapy in Pancreatic Adenocarcinoma
Condition: Pancreatic Adenocarcinoma
Interventions: Drug: Gemcitabine;   Drug: Nab-paclitaxel;   Drug: Durvalumab;   Drug: Tremilimumab
16 Not yet recruiting Anemia Studies in Chronic Kidney Disease: Erythropoiesis Via a Novel Prolyl Hydroxylase Inhibitor Daprodustat-Dialysis (ASCEND-D)
Condition: Anaemia
Interventions: Drug: Daprodustat;   Drug: rhEPO;   Drug: Placebo;   Drug: Iron therapy
17 Not yet recruiting Post-operative Outcomes in the Pyloromyotomy Procedure Under Spinal Anesthesia
Condition: Postoperative Pain
Intervention: Other: Spinal anesthesia
18 Recruiting Multi-segmental Robotic and Technological Upper Limb Rehabilitation in Stroke
Condition: Stroke
Interventions: Device: Amadeo, Pablo, Diego and Motore.;   Other: Conventional rehabilitation
19 Not yet recruiting Evaluating the Safety and Immunogenicity of a Tetravalent Dengue Vaccine (TetraVax-DV) TV005 in Flavivirus-Naive Adults 50 to 70 Years of Age
Condition: Dengue
Interventions: Biological: TetraVax-DV TV005;   Biological: Placebo
20 Recruiting Evaluation of Inter-patient Variability Size of the Nasal Cavity, Based on CT Scans
Condition: Nasal Cavity
Intervention:

   Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results    Last Page
Indicates status has not been verified in more than two years